Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (557)

  • Gomez-Centurion, I; Rojas, RMM; Bailen, R; Munoz, C; Sabell, S; Oarbeascoa, G; Fernandez-Caldas, P; Carbonell, D; Gayoso, J; Martinez-Laperche, C; Buno, I; Anguita, J; Diez-Martin, JL; Kwon, M.

    Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide

    ANNALS OF HEMATOLOGY. 2023; 102(6): 1561-1567 Nº de citas: 10 [doi:10.1007/s00277-023-05206-5]

  • Ibanez, JS; Bokhorst, A; Chandrasekar, A; Dominguez-Gil, B; Gayoso, J; Kaminski, A; Lomero, M; Lopez-Fraga, M; Worel, N.

    Protection of haematopoietic progenitor cell donors: an updated overview of the European landscape

    BONE MARROW TRANSPLANTATION. 2023; 58(8): 842-848 [doi:10.1038/s41409-023-01982-w]

  • Mussetti A; Kanate AS; Wang T; He M; Hamadani M; Finel H Sr; Boumendil A Sr; Glass B; Castagna L; Dominietto A; McGuirk J; Blaise D; Gülbas Z; Diez-Martin J; Marsh SGE; Paczesny S; Gadalla SM; Dreger P; Zhang MJ; Spellman SR; Lee SJ; Bolon YT; Sureda A.

    Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

    Transplantation And Cellular Therapy. 2023; 29(3): 1841-1849 Nº de citas: 6 [doi:10.1016/j.jtct.2022.11.028]

  • Errazquin, R; Carrasco, E; Del Marro, S; Sunol, A; Peral, J; Ortiz, J; Rubio, JC; Segrelles, C; Duenas, M; Garrido-Aranda, A; Alvarez, M; Belendez, C; Balmana, J; Garcia-Escudero, R.

    Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma

    Cancers. 2023; 15(6): Nº de citas: 7 [doi:10.3390/cancers15061871]

  • Martinez-Lopez, J; De la Cruz, J; Gil-Manso, R; Alegre, A; Ortiz, J; Llamas, P; Martinez, Y; Hernandez-Rivas, JA; Gonzalez-Gascon, I; Benavente, C; Monteliu, PE; Jimenez-Yuste, V; Canales, M; Bastos, M; Kwon, M; Valenciano, S; Callejas-Charavia, M; Lopez-Jimenez, J; Herrera, P; Duarte, R; Martin-Buitrago, LN; Godoy, PS; Yerovi, CJ; Martinez-Barranco, P; Roa, MG; Escobar, CE; Matilla, A; Sierra, BR; Alaez-Uson, MC; Quiroz-Cervantes, K; Martinez-Chamorro, C; Perez-Oteyza, J; Martos-Martinez, R; Herraez, R; Gonzalez-Santillana, C; Del Campo, JF; Alonso, A; de la Fuente, A; Pascual, A; Bustelos-Rodriguez, R; Sebrango, A; Ruiz, E; Marcheco-Pupo, EA; Grande, C; Cedillo, A; Lumbreras, C; Barea, AA; Casas-Rojo, JM; Calbacho, M; Diez-Martin, JL; Garcia-Suarez, J.

    COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers. 2023; 15(5): Nº de citas: 10 [doi:10.3390/cancers15051497]

  • Hermans, SJF; Versluis, J; Labopin, M; Giebel, S; van Norden, Y; Moiseev, I; Blaise, D; Martfn, JD; Meijer, E; Rovira, M; Choi, G; Raiola, AM; Koc, Y; RemTnyi, P; Vydra, J; Kroger, N; Sica, S; Martino, M; van Gorkom, G; Chevallier, P; Busca, A; Arroyo, CH; Brissot, E; Peric, Z; Nagler, A; Shouval, R; Ciceri, F; Cornelissen, JJ; Mohty, M.

    Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

    Hemasphere. 2023; 7(3): 846-846 Nº de citas: 5 [doi:10.1097/HS9.0000000000000846]

  • Rubia, JD; Gonzalez, B; Cruz-Jentoft, AJ; Iglesias, L; Jarque, I; Persona, EP; Lluch, R; Marrero, C; Zudaire, M; Gironella, M; Hernandez-Rivas, JA; Arnan, M; Olivier, C; Encinas, C; Soler, JA; Payer, AR; Casado, A; Fernandez, P; Vilanova, D; Bonanad, S.

    Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study

    Journal of Geriatric Oncology. 2023; 14(1): Nº de citas: 10 [doi:10.1016/j.jgo.2022.10.016]

  • Colino, CG; Catalan, MA; Honrubia, AM; Acosta, MJO; Abos, MG; Ribelles, AJ; Valero, JMV.

    Adolescent cancer care: What has changed in Spain in the past decade?

    ANALES DE PEDIATRIA. 2023; 98(2): 129-135 [doi:10.1016/j.anpedi.2022.09.012]

  • Andres-Zayas, C; Suarez-Gonzalez, J; Chicano-Lavilla, M; Oreiro, MB; Rodriguez-Macias, G; Lopez, PF; Prendes, SO; Royuela, GO; Ramirez, PG; Salgado, RN; Gomez-Centurion, I; Munoz, DC; Muniz, P; Kwon, M; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

    Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

    Cancers. 2023; 15(3): [doi:10.3390/cancers15030944]

  • Gonzalez-Lopez, TJ; Barez, A; Bernardo-Gutierrez, A; Bernat, S; Canaro-Hirnyk, M; Entrena-Urena, L; Fernandez-Fuertes, F; de Castro, JMG; Jimenez-Barcenas, R; Pascual-Izquierdo, C; Sanchez-Gonzalez, B; Jarque, I.

    Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group

    Infectious Diseases and Therapy. 2023; 12(2): 303-315 Nº de citas: 6 [doi:10.1007/s40121-022-00745-2]

  • Martinez, C; de Haro, ME; Romero, S; Gutierrez, A; Domingo-Domenech, E; Gonzalez-Rodriguez, AP; Zeberio, I; Martinez-Badas, MP; Rodriguez-Izquierdo, A; Carpio, C; Bastos-Oreiro, M; Hernandez-Rivas, JA; Vallansot, R; Kelleher, N; Diaz-Galvez, FJ; Torrado, T; Pereira, A; Garcia-Sanz, R.

    Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

    ANNALS OF HEMATOLOGY. 2023; 102(2): 429-437 Nº de citas: 6 [doi:10.1007/s00277-022-05011-6]

  • Ortuzar, A; Fox, ML; Vera, JA; Vizcaya, AL; Sanchez, AM; Calatayud, IL; Carbonell, S; Alvarez-Larran, A; Serna, RM; Buades, JEM; Cervantes, KQ; Hellin, AM; Dominguez, AB; Navarro, GC; Sansaloni, AC; Fernandez, LG; Linares, CM; Kabat, MG; Lopez, RP; Rodriguez, AF; Bilbao, CM; Rodriguez, MTC; Diaz, A; Duran, MA; Tomas, MS; Garcia-Gutierrez, V; Mazo, EM; Hernandez-Boluda, JC; Segura, A; Raya, JM; Elorza, BN; Osorio, S.

    Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain

    ANNALS OF HEMATOLOGY. 2023; 102(2): 447-456 Nº de citas: 2 [doi:10.1007/s00277-022-05044-x]

  • Muntanola, A; Mozas, P; Mercadal, S; Huguet, M; Bobillo, S; Bastos-Oreiro, M; Jimenez-Ubieto, A; Rovira, J; Rivero, A; Tolosa, C; Luizaga, L; de Villambrosia, SG; Novelli, S; Caballero, D; Salar, A; Alonso-Alvarez, S; Magnano, L; Gutierrez, NC; Sancho, JM; Lopez-Guillermo, A.

    Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome

    BRITISH JOURNAL OF HAEMATOLOGY. 2023; 200(3): 306-314 Nº de citas: 9 [doi:10.1111/bjh.18522]

  • Cruz, D; Rodriguez-Romanos, R; Gonzalez-Bartulos, M; Garcia-Cadenas, I; de la Camara, R; Heras, I; Buno, I; Santos, N; Lloveras, N; Velarde, P; Tuset, E; Martinez, C; Gonzalez, M; Sanz, GF; Ferra, C; Sampol, A; Coll, R; Perez-Simon, JA; Lopez-Jimenez, J; Jurado, M; Gallardo, D.

    LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

    Frontiers in Immunology. 2023; 14: Nº de citas: 3 [doi:10.3389/fimmu.2023.1066393]

  • Kwon, M; Iacoboni, G; Reguera, JL; Corral, LL; Morales, RH; Ortiz-Maldonado, V; Guerreiro, M; Caballero, AC; Dominguez, MLG; Pina, JMS; Mussetti, A; Sancho, JM; Bastos-Oreiro, M; Catala, E; Delgado, J; Henriquez, HL; Sanz, J; Calbacho, M; Bailen, R; Carpio, C; Ribera, JM; Sureda, A; Briones, J; Hernandez-Boluda, JC; Cebrian, NM; Martin, JLD; Martin, A; Barba, P.

    Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

    HAEMATOLOGICA. 2023; 108(1): 110-121 Nº de citas: 91 [doi:10.3324/haematol.2022.280805]

  • Estirado, AD; Garcia, GS; Aragones, JH; Colino, CG; Seoane-Reula, E; Fernandez, CM.

    Outcomes and impact of multidisciplinary team care on immunologic and hemato-oncologic pediatric patients

    ALLERGOLOGIA ET IMMUNOPATHOLOGIA. 2023; 51(1): 154-158 Nº de citas: 3 [doi:10.15586/aei.v51i1.627]

  • Porwit, A; Bene, MC; Duetz, C; Matarraz, S; Oelschlaegel, U; Westers, TM; Wagner-Ballon, O; Kordasti, S; Valent, P; Preijers, F; Alhan, C; Bellos, F; Bettelheim, P; Burbury, K; Chapuis, N; Cremers, E; Della Porta, MG; Dunlop, A; Eidenschink-Brodersen, L; Font, P; Fontenay, M; Hobo, W; Ireland, R; Johansson, U; Loken, MR; Ogata, K; Orfao, A; Psarra, K; Saft, L; Subira, D; te Marvelde, J; Wells, DA; van der Velden, VHJ; Kern, W; van de Loosdrecht, AA.

    Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group

    CYTOMETRY PART B-CLINICAL CYTOMETRY. 2023; 104(1): 27-50 Nº de citas: 26 [doi:10.1002/cyto.b.22108]

  • Santoro, N; Mooyaart, JE; Devillier, R; Koc, Y; Vydra, J; Castagna, L; Gulbas, Z; Martin, JD; Araujo, MC; Kulagin, A; Arat, M; Arroyo, CH; Martelli, MP; Di Ianni, M; Hoogenboom, JD; de Wreede, LC; Ruggeri, A; Chabannon, C.

    Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

    BONE MARROW TRANSPLANTATION. 2023; 58(1): 54-60 Nº de citas: 21 [doi:10.1038/s41409-022-01839-8]